AI assistant
AtriCure, Inc. — Director's Dealing 2021
Jul 6, 2021
31802_dirs_2021-07-06_af75360e-1a73-414f-9e36-590a14dc53b5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2021-07-01
Reporting Person: Collar Mark A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-01 | Common Stock | S | 3000 | $79.61 | Disposed | 81307 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5300 | Indirect |
Footnotes
F1: These shares were sold pursuant to a 10b5-1 trading plan.
F2: This transaction was executed in multiple trades at prices ranging from $79.19 to $80.18 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: The Reporting Person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.